Sampo Oyj (BIT:1SAMP)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,286	21,196	19,876	25,115	24,098	19,199
Market Cap Growth	22.29%	6.64%	-20.86%	4.22%	25.52%	-11.15%
Enterprise Value	27,823	22,709	21,727	26,407	25,205	23,852
PE Ratio	21.83	18.37	15.02	11.92	9.39	518.88
PS Ratio	2.70	2.23	2.40	2.93	1.70	2.20
PB Ratio	3.84	3.00	2.59	2.47	1.79	1.57
P/FCF Ratio	-	17.89	20.49	761.06	20.34	29.58
P/OCF Ratio	-	15.97	20.49	761.06	20.34	23.73
EV/Sales Ratio	2.85	2.39	2.63	3.08	1.78	2.73
EV/EBITDA Ratio	14.97	12.58	12.62	12.12	8.19	141.97
EV/EBIT Ratio	16.73	13.69	13.61	12.93	8.65	335.94
EV/FCF Ratio	17.92	19.16	22.40	800.21	21.27	36.75
Debt / Equity Ratio	0.42	0.45	0.39	0.36	0.33	0.42
Debt / EBITDA Ratio	1.53	1.71	1.72	1.64	1.44	26.90
Debt / FCF Ratio	1.83	2.66	3.11	110.00	3.78	8.00
Quick Ratio	1.58	1.55	1.64	0.66	0.31	0.51
Current Ratio	1.82	1.83	1.90	0.89	0.55	0.63
Asset Turnover	0.39	0.39	0.26	0.17	0.24	0.16
Return on Equity (ROE)	17.21%	16.68%	12.78%	13.19%	21.37%	0.90%
Return on Assets (ROA)	4.18%	4.26%	3.15%	2.55%	3.10%	0.08%
Return on Capital (ROIC)	10.39%	9.92%	8.14%	8.04%	10.29%	0.26%
Earnings Yield	4.58%	5.44%	6.66%	8.39%	10.65%	0.19%
Earnings Yield	4.58%	5.44%	6.66%	8.39%	10.65%	0.19%
FCF Yield	5.91%	5.59%	4.88%	0.13%	4.92%	3.38%
Payout Ratio	76.00%	78.25%	99.85%	53.16%	36.77%	2251.35%
Buyback Yield / Dilution	-5.55%	-1.22%	4.59%	4.33%	0.19%	-

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.